Endexx to Develop Consumable CBD Products
April 09 2014 - 6:15AM
Marketwired
Endexx to Develop Consumable CBD Products
Endexx Engages Todd Zarlengo to Act as Co-Developer of CBD and
Medical Marijuana Consumable Division
CAVE CREEK, AZ--(Marketwired - Apr 9, 2014) - Endexx Corporation
(OTC Pink: EDXC) (PINKSHEETS: EDXC), a provider of innovative
medical marijuana management and technology solutions, announces a
collaboration agreement with Todd Zarlengo, a leading Italian
dessert chef and entrepreneur, to develop the manufacturing,
packaging and labeling protocols for the successful launch of
Endexx's new medical marijuana consumable division. The new
division will focus on edible delivery systems for medical
applications of cannabidiol extracts in the form of CBD-infused
"cannsumer" goods for the rapidly growing $1.5 billion U.S. medical
marijuana market.
Todd Zarlengo stated: "Like my father Tom, I have dedicated my
life to the art of hand-made, artisanal ice cream, Italian ice,
gelato and sorbet. Our family has been in the business of
wholesaling and retailing frozen desserts for 31 years and I am
overjoyed to bring my expertise in manufacturing premium quality
frozen desserts to Endexx. We are excited to introduce the first
product line of our all-new 'Cannsumer Goods' division. The
debut of our new and exciting line of 'Cannsumable' products will
feature all natural, CBD-infused liquid and frozen
desserts. The line combines the medicinal properties of CBD in
an assortment of fruit flavors that are absolutely
delicious."
Todd Davis, Chairman and CEO of Endexx, said, "Mr. Zarlengo
brings expertise and passion to our new Cannsumable product line.
He will collaborate in all aspects of the success of this new
division and unique product line. His experience in freezable and
frozen products immediately positions Endexx for market leadership
in CBD-infused edible products for use by patients and consumers
seeking alternative therapeutic support. In addition, Mr.
Zarlengo's experience in wholesaling and retailing will be crucial
in building a profitable enterprise from its inception."
Cannabidiol (CBD) is a non-psychoactive natural compound that
has been shown in scientific and clinical studies to possess
beneficial properties in the treatment of a wide range of
conditions, including arthritis, diabetes, MS, PTSD, skin cancer,
epilepsy and other disorders. As mounting scientific evidence
proves the efficacy of CBD in treating a wide variety of
debilitating conditions, traditionally conservative states that
have not supported legalization of medical marijuana are
introducing legislation to legalize the use of CBD in treating
medical conditions. In the last 30 days, Alabama, Georgia,
Tennessee, Kentucky, Indiana, Wisconsin, Utah and Florida all have
introduced or passed bills to legalize the use of CBD in the
treatment of epilepsy and other debilitating conditions. Recent
media coverage around the use a strain of cannabis called
"Charlotte's Web," popular for its high CBD count and used to treat
seizure-related disorders, has raised the profile of CBD's
benefits.
About Endexx :
www.endexx.com www.gsgsolar.com www.m3hub.com
www.autospense.com
Endexx Corporation collaborates with independent software
engineers and architects, scientists, engineers, and other
innovators to build businesses that can thrive collectively in the
equity markets. The Endexx team recognizes that individually,
development stage technology companies face extreme difficulty
surviving as independent organizations. Through its collaborative
practices, individual and group skill sets are synergistically
applied to develop unique technologies and grow the businesses,
while centralizing costs and eliminating redundancies. Endexx
provides a platform for entrepreneurs to thrive, offering maximum
return on investment through equity ownership in the parent
corporation. Each entrepreneur is an Endexx shareholder,
incentivized to contribute to the overall objective of increasing
shareholder value. Endexx's management team and its advisory
group each have a minimum of 10-50 years of experience in their
field of expertise. The parent company's management has extensive
experience growing businesses, developing and implementing new
technologies and running publicly traded corporations.
Contact Endexx via email to receive corporate news and updates
at Endexx@endexx.com.
http://www.otcmarkets.com/stock/EDXC/quote
Safe Harbor Notice: This press release may contain
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995, such as statements
relating to financial results and plans for future development
activities, and are thus prospective. Forward-looking statements
include all statements that are not statements of historical fact
regarding intent, belief or current expectations of the Company,
its directors or its officers. Investors are cautioned that any
such forward-looking statements are not guarantees of future
performance and involve risks and uncertainties, many of which are
beyond the Company's ability to control. Actual results may differ
materially from those projected in the forward-looking statements.
Among the factors that could cause actual results to differ
materially from those indicated in the forward-looking statements
are risks and uncertainties associated with the Company's business
and finances in general, including the ability to continue and
manage its growth, competition, global economic conditions and
other factors discussed in detail in the Company's periodic filings
with the Security and Exchange Commission. The Company undertakes
no obligation to update any forward-looking statements.
Endexx Corporation Todd Davis Chairman & CEO
endexx@endexx.com M3Hub Sales: 480-999-0097
Investor Relations IRTH Communications Andrew Haag Managing Partner
EDXC@irthcommunications.com 866-976-4784
Endexx (PK) (USOTC:EDXC)
Historical Stock Chart
From Apr 2024 to May 2024
Endexx (PK) (USOTC:EDXC)
Historical Stock Chart
From May 2023 to May 2024